Cannabis use disorder and adverse cardiovascular outcomes: A population‐based retrospective cohort analysis of adults from Alberta, Canada
Addiction · 2024
DOI: 10.1111/add.16337 ↗At a glance
Journal article in Addiction, 2024. Written by Anees Bahji and 6 co-authors. Institution: Department of Psychiatry, University of Calgary, Calgary, AB, Canada. Major MEDLINE topics: Marijuana Abuse, Cardiovascular Diseases, Substance-Related Disorders, Cannabis. Cited 18 times so far (Crossref); 87 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: NIDA NIH HHS.
Abstract (original language)
Aim
To measure the association between cannabis use disorder (CUD) and adverse cardiovascular disease (CVD) outcomes. Design and Setting We conducted a matched, population‐based retrospective cohort study involving five linked administrative health databases from Alberta, Canada.
Participants
We identified participants with CUD diagnosis codes and matched them to participants without CUD codes by gender, year of birth and time of presentation to the health system. We included 29 764 pairs ( n = 59 528 individuals in total).
Measurements
CVD events were defined by at least one incident diagnostic code within the study period (1 January 2012–31 December 2019). Covariates included comorbidity, socio‐economic status, prescription medication use and health service use. Using mortality‐censored Poisson regression models, we computed survival analyses for time to incident CVD stratified by CUD status. In addition, we calculated crude and stratified risk ratios (RRs) across various covariates using the Mantel–Haenszel technique.
Findings
The overall prevalence of documented CUD was 0.8%. Approximately 2.4% and 1.5% of participants in the CUD and unexposed groups experienced an incident adverse CVD event (RR = 1.57; 95% confidence interval = 1.40–1.77). CUD was significantly associated with reduced time to incident CVD event. Individuals who appeared to have greater RRs for incident CVD were those without mental health comorbidity, who had not used health‐care services in the previous 6 months, who were not on prescription medications and who did not have comorbid conditions.
Conclusions
Canadian adults with cannabis use disorder appear to have an approximately 60% higher risk of experiencing incident adverse cardiovascular disease events than those without cannabis use disorder.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Psychiatry, University of Calgary, Calgary, AB, Canada.
- Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.
- Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
- British Columbia Centre on Substance Use, Vancouver, BC, Canada.
- Canadian Research Initiative in Substance (CRISM)-Alberta Health Services (AHS) Advances of Analytics in Substance Use, Edmonton, AB, Canada.
- University of Alberta, Edmonton, AB, Canada.
ORCID profiles: Anees Bahji, E Jennifer Edelman
Funding
- NIDA NIH HHS
Cite
APA
Bahji, A., Hathaway, J., Adams, D., Crockford, D., Edelman, E. J., Stein, M. D., & Patten, S. B. (2024). Cannabis use disorder and adverse cardiovascular outcomes: A population‐based retrospective cohort analysis of adults from Alberta, Canada. Addiction. https://doi.org/10.1111/add.16337
Vancouver
Bahji A, Hathaway J, Adams D, Crockford D, Edelman EJ, Stein MD, et al. Cannabis use disorder and adverse cardiovascular outcomes: A population‐based retrospective cohort analysis of adults from Alberta, Canada. Addiction. 2024. doi:10.1111/add.16337
BibTeX
@article{Bahji2024,
author = {Bahji, Anees and Hathaway, Josh and Adams, Denise and Crockford, David and Edelman, E Jennifer and Stein, Michael D and Patten, Scott B},
title = {Cannabis use disorder and adverse cardiovascular outcomes: A population‐based retrospective cohort analysis of adults from Alberta, Canada},
journal = {Addiction},
year = {2024},
doi = {10.1111/add.16337}
}
EUVIMED